Cannovum Cannabis AG Logo

Cannovum Cannabis AG

Licensed importer, wholesaler, and manufacturer of medical cannabis products.

27N0 | DU

Overview

Corporate Details

ISIN(s):
DE000A30VHF2 (+2 more)
LEI:
894500IT61F9P85YMM31
Country:
Germany
Address:
Stresemannstraße 23, 10963 Berlin

Description

Cannovum Cannabis AG is a pharmaceutical company that operates as a licensed importer, wholesaler, and manufacturer of high-quality medical cannabis products. The company's primary focus is on supplying the medical market and providing patients with therapeutic options. In response to evolving regulations, Cannovum is also strategically positioning itself for the legalized recreational cannabis market. This includes initiatives aimed at public education and brand awareness, alongside developing a product portfolio for the adult-use consumer segment. The company is also engaged in expanding its operations into other European markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-27 21:05
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
English 5.8 KB
2025-02-26 21:05
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
English 5.8 KB
2024-08-01 07:36
Cannovum Cannabis AG: Far-reaching partnership with H.i. Greeny+ GmbH and H.i C…
English 9.4 KB
2024-06-26 09:34
Cannovum Cannabis AG: 'Cannabis for Germany', sale of fake hemp in 1,000 Aldi S…
English 9.0 KB
2024-06-07 07:00
Cannovum Cannabis AG: Bundestag confirms Cannovum Cannabis AG's business model …
English 7.6 KB
2024-06-04 10:20
Cannovum Cannabis AG: Cash capital increase from authorized capital with subscr…
English 5.9 KB
2024-03-22 11:45
Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of Apri…
English 9.5 KB
2024-03-05 09:30
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in t…
English 9.0 KB
2024-03-05 06:59
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in t…
English 9.1 KB
2024-02-23 15:51
Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, h…
English 8.1 KB
2024-02-02 09:37
Cannovum Cannabis AG: April 2024 starts the legalization of cannabis in Germany…
English 7.8 KB
2023-11-14 15:55
Cannovum Cannabis AG: High-profile business leaders from advertising and retail…
English 7.3 KB
2023-11-06 13:39
Cannovum Cannabis AG: Legalization of cannabis is imminent, new premium partner…
English 10.6 KB
2023-08-07 07:30
Cannovum Cannabis AG: Exclusive partnership and million-dollar sales potential …
English 9.2 KB
2023-07-17 10:47
Cannovum Cannabis AG: New partner strengthens offer for private cultivation of …
English 10.4 KB

Automate Your Workflow. Get a real-time feed of all Cannovum Cannabis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cannovum Cannabis AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cannovum Cannabis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.